Posted in | News

Fermilab Physicist Observes New Particle

At a recent physics seminar at the Department of Energy's Fermi National Accelerator Laboratory, Fermilab physicist Pat Lukens of the CDF experiment announced the observation of a new particle, the Omega-sub-b. The particle contains three quarks, two strange quarks and a bottom quark (s-s-b). It is an exotic relative of the much more common proton and has about six times the proton's mass.

The observation of this "doubly strange" particle, predicted by the Standard Model, is significant because it strengthens physicists' confidence in their understanding of how quarks form matter. In addition, it conflicts with a 2008 result announced by CDF's sister experiment, DZero.

The Omega-sub-b is the latest entry in the "periodic table of baryons." Baryons are particles formed of three quarks, the most common examples being the proton and neutron. The Tevatron particle accelerator at Fermilab is unique in its ability to produce baryons containing the b quark, and the large data samples now available after many years of successful running enable experimenters to find and study these rare particles. The observation opens a new window for scientists to investigate its properties and better understand this rare object.

Combing through almost half a quadrillion (1000 trillion) proton-antiproton collisions produced by Fermilab's Tevatron particle collider, the CDF collaboration isolated 16 examples in which the particles emerging from a collision revealed the distinctive signature of the Omega-sub-b. Once produced, the Omega-sub-b travels a fraction of a millimeter before it decays into lighter particles. This decay, mediated by the weak force, occurs in about a trillionth of a second. In fact, CDF has performed the first ever measurement of the Omega-sub-b lifetime and obtained 1.13 +0.53-0.40(stat.) ±0.02(syst.) trillionths of a second.

In August 2008, the DZero experiment announced its own observation of the Omega-sub-b based on a smaller sample of Tevatron data. Interestingly, the new CDF observation announced here is in direct conflict with the earlier DZero result. The CDF physicists measured the Omega-sub-b mass to be 6054.4 ± 6.8(stat.) ± 0.9(syst.) MeV/c2, compared to DZero's 6165 ± 10(stat.) ± 13(syst.) MeV/c2. These two experimental results are statistically inconsistent with each other leaving scientists from both experiments wondering whether they are measuring the same particle. Furthermore, the experiments observed different rates of production of this particle. Perhaps most interesting is that neither experiment sees a hint of evidence for the particle at the other's measured value.

Although the latest result announced by CDF agrees with theoretical expectation for the Omega-sub-b both in the measured production rate and in the mass value, further investigation is needed to solve the puzzle of these conflicting results.

The Omega-sub-b discovery follows the observation of the Cascade-b-minus baryon, first observed at the Tevatron in 2007, and two types of Sigma-sub-b baryons, discovered at the Tevatron in 2006.

The CDF collaboration submitted a paper that summarizes the details of its discovery to the journal Physical Review D. It is available online at: http://arxiv.org/abs/0905.3123

CDF is an international experiment of about 600 physicists from 62 institutions in 15 countries. It is supported by the U.S. Department of Energy, the National Science Foundation and a number of international funding agencies. Fermilab is a national laboratory funded by the Office of Science of the U.S. Department of Energy, operated under contract by Fermi Research Alliance, LLC.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.